Skip to content

Bio-Techne TECH Research and development expense

Research and development expense at other companies

ON Semiconductor logo
ON SemiconductorON
$144.3M-12.1%
TG Therapeutics logo
TG TherapeuticsTGTX
$43.52M+1.1%
Corvex
 logo
Corvex MOVE
$899K+12.4%
Monolithic Power Systems logo
Monolithic Power SystemsMPWR
$100.57M+9.0%
Boston Scientific logo
Boston ScientificBSX
$516M+16.5%
Teradyne, Inc. logo
Teradyne, Inc.TER
$135.56M+14.7%

Segments

By segment

See full
Protein Sciences$14.45M-2.2%
Diagnostics And Spatial Biology$9M-11.7%

Other financials

Income statement

See full
Revenue$311.4M-1.5%
Gross profit$208.3M-2.9%
Operating income$75.5M+95.0%
Net income$51.0M+126%
EPS (diluted)$0.32+129%

Balance sheet

See full
Cash & equivalents$209.8M+49.2%
Total debt$290.3M-31.4%
Total equity$2.1B+3.3%
Total assets$2.6B-3.5%

Cash flow

See full
Operating cash flow$86.7M+111%
CapEx$9.1M-10.2%
Free cash flow$77.6M+150%

Valuation

See full
Market cap$9.07B-11.8%
Enterprise value$9.15B-13.6%
P/E60.6×+13.6×
P/S7.5×-1.0×

Profitability

See full
Gross margin65%-0.8pp
Operating margin14.2%-7.9pp
Net margin10.9%-6.7pp
FCF margin22.3%+4.0pp

Returns & leverage

See full
Return on equity6.5%-3.9pp
Debt / equity0.1×-0.1×
Current ratio4.5×+0.8×

Where this comes from

Reported directly by Bio-Techne in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost.

The official record: Bio-Techne’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bio-Techne's research and development expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bio-Techne's research and development expense?
Bio-Techne (TECH) reported research and development expense of $23.46M in Q1 2026.
How has Bio-Techne's research and development expense changed year-over-year?
Bio-Techne's research and development expense decreased by 4.6% year-over-year, from $24.58M to $23.46M.
What is the long-term trend for Bio-Techne's research and development expense?
Over 3 years (2022 to 2025), Bio-Techne's research and development expense has grown at a 4.5% compound annual growth rate (CAGR), from $87.14M to $99.5M.